Reproducibility-Aware AI Drug Models Hit Clinical Wins, Now Partnering With Pharma
MaxUnfried · x · 2026-10-08
At the ARDD aging-research meeting, Dr. Alex Voda's team presented reproducibility-aware AI drug discovery models that improved their pipeline and delivered clinical trial successes — first in feline medicine, dramatically improving blood urea, creatinine and blood phosphorus in elderly cats with kidney disease.
They detailed how the proprietary data moat could transfer to human (and other mammalian) medicine, targeting kidney, musculoskeletal and brain age-related diseases. The team is now partnering with pharma companies to bring therapeutics to market, with strong follow-up interest from attendees.
More from Apps
- One user's daily agent stack: 7 AI agents split by task, with OpenAI's Dots starting a business — omooretweets · 2026-10-08
- Instinct rebuilds flight search and booking after 20% of users used it for travel — chetanp · 2026-10-08
- xAI Launches Grok Bot Marketplace With Connectable Apps and Community Bots — nicolascraske · 2026-10-08
- How to find and use Nano Banana 2.1 in Google AI Studio — Matthew Berman · 2026-10-08
- Luke Wroblewski tests Google's new image model: faster, cheaper, better — LukeW · 2026-10-08
- OpenAI rolls out ChatGPT plugin extensions with sidebar launch, @ mentions and file viewers — OpenAIDevs · 2026-10-08